Sugi Predict

Sugi Predict / Compounds / SCHEMBL6883476

SCHEMBL6883476

SCHEMBL6883476

Cc1nc2cccc(-c3ccccc3)c2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.53
▸ ADORA2A P29274 1/20 0.53
▸ ADORA1 P30542 1/20 0.53
▸ PARP1 P09874 4/20 0.47
▸ TNKS2 Q9H2K2 1/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ NPC1 O15118 5/20 0.41
▸ RAB9A P51151 5/20 0.41
▸ ACVR1 Q04771 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ PDGFRA P16234 1/20 0.41
▸ LTK P29376 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ MAPK8 P45983 1/20 0.41
▸ CSNK1A1 P48729 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12723041 0.85 PARP1 (0.43) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL8589064 0.83 PDCD1 (0.44) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL13469323 0.82 ADORA3 (0.44) ADORA3ADORA2AADORA1PARP1ACVR1
SCHEMBL13469300 0.81 PARP1 (0.53) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL27761849 0.80 NPC1 (0.56) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL5586200 0.79 ADORA3 (0.50) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL27479714 0.79 ADORA3 (0.50) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL9306192 0.79 MAP4K4 (0.41) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL7146757 0.79 NPC1 (0.55) ADORA3ADORA2AADORA1PARP1TNKS2
SCHEMBL11707809 0.79 FGFR1 (0.49) SMN1; SMN2KDM4EHPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0428260-A2 Metal surface treatment agents SANWA LABORATORY LTD. (JP) 1991-05-22 — — EP claimed
CN-109566351-B Culture medium for improving germination rate 上海派布利克贸易有限公司 2021-10-26 — — CN disclosed
CN-109566374-B High-yield pea seedling and planting method thereof 刘斌 2021-04-06 — — CN disclosed
CN-109566374-A A kind of high yield pea seedlings and its implantation methods 李靖 2019-04-05 — — CN disclosed
CN-109566351-A A kind of culture substrate improving bud ratio 李靖 2019-04-05 — — CN disclosed
EP-2491041-B1 BIVALENT DIAZO BICYCLIC SMAC MIMETICS AND THE USES THEREOF UNIV MICHIGAN REGENTS (US) 2017-08-09 — — EP disclosed
EP-2707372-B1 SPIRO-OXINDOLE MDM2 ANTAGONISTS UNIV MICHIGAN REGENTS (US) 2016-12-21 — — EP disclosed
US-20160115136-A1 COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO UNIVERSITY OF IOWA RESEARCH FOUNDATION 2016-04-28 — — US disclosed
US-9302120-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-04-05 — — US disclosed
EP-2499145-B1 SPIRO-OXINDOLE MDM2 ANTAGONISTS UNIV MICHIGAN (US) 2016-01-27 — — EP disclosed
US-8680132-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-03-25 — — US disclosed
US-8629141-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-01-14 — — US disclosed
US-20130296303-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-11-07 — — US disclosed
US-8518984-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2013-08-27 — — US disclosed
US-8445473-B2 Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2013-05-21 — — US disclosed
US-20120289494-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS SANOFI (FR) 2012-11-15 — — US disclosed
US-20120263675-A1 BIVALENT DIAZO BICYCLIC SMAC THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2012-10-18 — — US disclosed
WO-2011127058-A2 BIOMARKERS FOR MDM2 INHIBITORS FOR USE IN TREATING DISEASE THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-10-13 — — WO disclosed
US-20110112052-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-05-12 — — US disclosed
WO-2011050068-A2 BIVALENT DIAZO BICYCLIC SMAC MIMETICS AND THE USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-04-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160115136-A1 COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO LPO, NOTUM, FARS2 ADORA3 1189/4885ADORA2A 1565/4885ADORA1 837/4885
US-20110112052-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS TP53, MDM2, TP53BP1 ADORA3 3445/4885ADORA2A 2027/4885ADORA1 3634/4885
US-20120289494-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS TP53, MDM2, TP53BP1 ADORA3 3445/4885ADORA2A 2027/4885ADORA1 3634/4885
US-20120263675-A1 BIVALENT DIAZO BICYCLIC SMAC BIRC2, BID, BIRC3 ADORA3 3336/4885ADORA2A 2963/4885ADORA1 3718/4885
US-20130296303-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS TP53, MDM2, TP53BP1 ADORA3 3445/4885ADORA2A 2027/4885ADORA1 3634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.